Comparative Evaluation of Antimicrobial Efficacy, Clinical and Radiographic Success of Calcium Hydroxide, Chlorhexidine, and Modified Triple Antibiotic Paste in Different Combination Forms As Intracanal Medicaments Against Enterococcus Faecalis in Primary Teeth
2 other identifiers
interventional
32
0 countries
N/A
Brief Summary
Comparing between different intracanal medications with different combination forms of Modified Triple Antibiotic Paste, Calcium Hydroxide and Chlorehexidine, regarding antimicrobial efficacy through bacterial reduction count of enterococcus Faecalis and regarding clinical and radiographic success in non vital primary teeth necessitating pulpectomy with follow up time 1 year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2024
CompletedFirst Posted
Study publicly available on registry
October 3, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedOctober 17, 2024
October 1, 2024
4 months
September 28, 2024
October 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Enterococcus faecalis bacterial reduction
Samples from canal using paper point size 20 with pumping action from the widest canal three times one after the access and gaining patency, second one after chemomechanical preparation and the third one after 7 days from intracanal medication insertion in the canal, then the samples will be placed in sterile vials with thioglycolate (transport medium). The vials will be sealed tightly to avoid contamination and labeled. The labeled vials will be kept in a freezer and will be sent to the laboratory within 1 hour of collection, and samples will be assessed for total E. faecalis count.
3 times, one after the access and gaining patency, second one after chemomechanical preparation and the third one after 7 days from intracanal medication insertion in the canal
Secondary Outcomes (1)
Clinical success
3,6 and 12 months
Other Outcomes (1)
Radiographic success
6 and 12 months
Study Arms (2)
Calcium Hydroxide mixed with saline as control intracanal medication
ACTIVE COMPARATORusing calcium hydroxide with saline as control intracanal medication for necrotic primary molars
different types and combinations of intracanal medications for necrotic primary molars
EXPERIMENTALInterventions
M-TAP with CHX 2%
M-TAP mixed with saline
calcium hydroxide powder mixed with CHX 2% solution as intracanal medication
calcium hydroxide mixed with saline as intracanal medication for necrotic primary molars
Eligibility Criteria
You may qualify if:
- Primary molars necessitating pulpectomy diagnosed with deep dental caries with pulp necrosis, apical periodontitis and periapical pathosis or both.
- Non-Vital pulps.
- Negative response to hot or cold pulp tester (ethyl chloride spray ).
- Decayed tooth with spontaneous unprovoked long dull aching pain showing signs of necrosis of the pulp
You may not qualify if:
- Medically compromised and uncooperative children
- Tooth indicated for extraction
- Mobile teeth (Miller's Grade 2 or more)
- teeth with more than two-thirds of root resorption
- previous endodontic treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
September 28, 2024
First Posted
October 3, 2024
Study Start
January 1, 2025
Primary Completion
May 1, 2025
Study Completion
January 1, 2026
Last Updated
October 17, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share